Halil İbrahim İNAKÇI, ZEYNEP ŞİMŞEK, İBRAHİM KORUK, Süda Tekin KORUK

Coverage of tetanus vaccine after national tetanus vaccination campain and basic determinants in Şanlıurfa

AMAÇ: Tetanoz yıllık yaklaşık 180.000 ölüme neden olan ve aşı ile önlenebilen bir hastalıktır. Bu çalışmanın amacı, ulusal aşı kampanyası sonrasında 15-49 yaşları arasındaki kadınlarda tetanoz aşısının kapsayıcılığını, temel belirleyicilerini saptamak ve Şanlıurfa’da aşılama çalışmalarını geliştirmek için gerekli yaklaşımları belirlemektir. YÖNTEM: Kesitsel tipteki bu araştırmada, ulusal aşı kampanyası sonrasında Kasım 2006-Ocak 2007 tarihleri arasında, Şanlıurfa ilinin kentsel ve kırsal alanlarını temsil edecek büyüklükte 15-49 yaşları arasındaki kadınlardan %95 güven düzeyinde 511 kadın LOT (LOT Kalite Yöntemi) kullanılarak seçilmiştir. ‘Sosyo-demografik Bilgi Formu’, ‘Kadın Aşılama Formu’, ve ‘Aşı Başarısızlık nedenleri Formu’ kullanılarak veri toplanmıştır. BULGULAR: Tetanoz kapsayıcılığının (2 ve daha fazla doz) lokalitelere göre %15 ile %70.5 arasında olduğu saptanmıştır. Yüksek riskli bu bölgede ulusal aşı kampanyası sonrasında Genişletilmiş Bağışıklama Programı amaçlarına ulaşılamamıştır. Kadının öğrenim durumu ve doğum öncesi bakım istatistiksel açıdan önemli belirleyicilerdir (p

Şanlıurfa’da ulusal aşı kampanyası sonrasında tetanoz aşısının kapsayıcılığı ve temel belirleyicileri

AIM: Tetanus is a vaccine-preventable disease that yearly causes a total of 180.000 deaths. The objective of this study was to examine the coverage vaccination of tetanus in women aged 15-49 years after the national vaccination campaigne and to determine related factors to vaccination in order to establish approaches for improving vaccination services in Sanliurfa. METHOD: In this cross-sectional survey, after a national tetanus vaccination campain, a population-based sample of 511 women aged 15–49 year was selected from rural and urban areas of Sanliurfa, between November 2006-January 2007, by using LOT (Lot Quality Sampling Method), at %95 confidence level. ‘Socio-demographic Information Form’, ‘Women Vaccination Form’, and ‘Reasons for Vaccination Failure Form’ were used to data collection. RESULTS: The TT vaccination coverage rate (with two or more doses) fluctuated from 15% to 70.5%. We did not meet the aim of the EPI with the national campaign in this a high risk area. The majority of the barriers are related to knowledge, and health management. Education of women and antenatal care were found significant predictors (p<0.05). CONCLUSION: The vaccination services is obligatory within the the primary health care services according to the Act of Socialization of Health Services in Turkey. Interventions must be necessary for improving the health management and health education which are the most important steps for increasing the vaccination rate.

PDF

___

1. Roper MH, Vandelaer JH, Gasse F. Maternal and neonatal tetanus. Lancet. 2007; 370: 1947-59.
2. World Health Organization, UNICEF, UNFPA. Maternal and neonatal tetanus elimination by 2005. Strategies for achieving and maintaining elimination. Geneva. World Health Organization, UNICEF, UNFPA. 2000.
3. World Health Organization, Global Immunization Data._http://www.who.int/immunization/newsroo m/Global_Immunization_Data.pdf [Access date 20 March 2009].
4. World Health Organization. Expanded Program on Immunization. Immunization policy. Geneva. 1996.
5. Ozcebe H. The status of child health and child survival and development programs in Turkey. Turk J Pediatr. 1998; 40: 217—30.
6. Annual Report of General Directorate of Primary Health Care, Ministry of Health. Ankara. Ministry of Health 2006. 2007: 65.
7. World Health Organization. Monitoring immunization services using the lot quality technique. Global Programme for vaccines and immunization vaccine research and development. Geneva. 1996.
8. Vandelaer J, Birmingham M, Gasse M, Kurian M, Shaw C, Garnier S. Tetanus in developing countries: an update on the Maternal and Neonatal Tetanus Elimination Initiative. Vaccine. 2003; 21: 3442–5.
9. Maral I, Baykan Z, Aksakal FN, Kayikcioglu F, Bumin MA. Tetanus immunization in pregnant women: evaluation of maternal tetanus vaccination status and factors affecting rate of vaccination coverage. Public Health. 2001; 115: 359–364.
10. Masuno K, Xaysomphoo D, Phengsavanh A, Douangmala S, Kuroiwa C. Scaling up interventions to eliminate neonatal tetanus: factors associated with the coverage of tetanus toxoid and clean deliveries among women in Vientiane, Lao PDR. Vaccine. 2009; 27(32): 4284-8.
11. Expanded Programme on Immunization. Pregnant women and antenatal care. Weekly Epidemiol Rec. 2004; 79: 143-4.
12. Griffiths UK, Wolfson LJ, Qudud A, Younus M, Hafız RA. Incremental cost-effectiveness of supplementary immunization activities to prevent neonatal tetanus in Pakistan. Bull World Health Organ. 2004; 82: 643-51.
13. Carr JE, Clements CJ, Martin RM, Pierre L, Ritchie J. Behavioural factors in immunization. World Health Organization. Geneva. www.who.int/mental_health/media/en/28.pdf._(Ac cess date 21 March 2009).